How Moderna, Inc. stacks up

MRNA · against 44 other Healthcare companies of similar size

Overall

18/ 100

Near the bottom of its peers.

Ranked #45 of 45 · scores higher than 0% of peers

Bars: peers in each 10-point band of the overall score

1 peers with an overall score of 10–19, including MRNA · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#43 of 44Score 8 / 100 · beats 0%Growth#43 of 43Score 5 / 100 · beats 0%Profitability#45 of 45Score 14 / 100 · beats 0%Risk#14 of 45Moderate relative risk · safety 45 · beats 70%

Ranking by overall score

Top 5 and the companies ranked around MRNA

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	argenx SEARGX · US-listed	56.7B USD	79	42	96	93	0 / 2
2	WuXi AppTec Co., Ltd.2359.HK · Hong Kong	534.1B HKD (≈$68.4B)	75	72	76	96	1 / 2
2	Jiangsu Hengrui Pharmaceuticals Co.,Ltd600276.SS · China	327.3B CNY (≈$45.8B)	75	49	64	96	0 / 2
2	HOYA Corporation7741.T · Japan	8.24T JPY (≈$56.0B)	75	57	63	98	0 / 2
5	Samsung Biologics Co.,Ltd.207940.KS · South Korea	67.60T KRW (≈$48.7B)	72	50	82	93	1 / 2
⋯
41	Pfizer Inc.PFE · US-listed	171.0B USD	45	66	14	68	2 / 2
42	Teva Pharmaceutical Industries LimitedT1EV34.SA · Brazil	272.9B BRL (≈$49.1B)	43	54	44	67	2 / 2
43	Natera, Inc.NTRA · US-listed	56.0B USD	39	8	86	26	1 / 2
44	Takeda Pharmaceutical Company LimitedTAK · US-listed	66.3B USD	30	44	20	37	2 / 2
45	Moderna, Inc.MRNA · US-listed	91.2B USD	18	8	5	14	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…